600+ Global VC backed Precision Medicine startups
View on Dealroom
The precision medicine sector focuses on tailoring healthcare to the unique genetic, molecular, and clinical characteristics of each patient. It combines genomics, advanced diagnostics, data analytics, and targeted therapies to deliver treatments that are more effective and less harmful than one-size-fits-all approaches. Companies in this space develop tools to analyze individual biology, identify actionable biomarkers, guide therapy decisions, and create personalized drugs or interventions. As a result, precision medicine is transforming disease prevention, diagnosis, and treatment—especially in oncology, rare diseases, and chronic conditions—by enabling more accurate predictions of patient response and improved clinical outcomes.